Influence of antidiabetic drugs on glucose metabolism and immune response in patients with metastatic pancreatic ductal adenocarcinoma receiving gemcitabine plus nab-paclitaxel as first-line treatment.

Andrea Pretta,Pina Ziranu,Riccardo Giampieri,Clelia Donisi,Erika Cimbro,Dario Spanu,Eleonora Lai,Federica Pecci,Francesca Balconi,Alessio Lupi,Marta Pozzari,Mara Persano,Sara Murgia,Valeria Pusceddu,Marco Puzzoni,Rossana Berardi,Mario Scartozzi

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver（2023）

引用 0|浏览13

暂无评分

摘要

Results showed a correlation between treated DM2 and higher mOS in patients with mPDAC. Limitations due to retrospective data collection must be considered. Further studies in this setting are needed.

查看译文

关键词

metastatic pancreatic ductal adenocarcinoma,antidiabetic drugs,glucose metabolism,nab-paclitaxel,first-line

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要